Smiles: OC(CCSC[C@@H]1[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]4[C@H](O)[C@@H](O)[C@H](O5)[C@@H](CSCCC(O)=O)O4)[C@@H](CSCCC(O)=O)O3)[C@@H](CSCCC(O)=O)O2)[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@@H]7[C@@H](CSCCC(O)=O)O[C@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)[C@@H]5O[C@@H]9CSCCC(O)=O)OC8CSCC%10[C@@H](O[C@@H]%11[C@H](O)[C@@H](O)[C@H](O%12)[C@@H](CSCCC(O)=O)O%11)[C@H](O)[C@@H](O)[C@@H](O[C@H]%13[C@H](O)[C@@H](O)[C@@H](O[C@H]%14[C@H](O)[C@@H](O)[C@@H](O[C@H]%15[C@H](O)[C@@H](O)[C@@H](O[C@@H]%16[C@@H](CSCCC(O)=O)O[C@H](O[C@H]%17[C@H](O)[C@@H](O)[C@@H](O[C@H]%18[C@H](O)[C@@H](O)[C@@H]%12O[C@@H]%18CSCCC(O)=O)O[C@@H]%17CSCCC(O)=O)[C@H](O)[C@H]%16O)O[C@@H]%15CSCCC(O)=O)O[C@@H]%14CSCCC(O)=O)O[C@@H]%13CSCCC(O)=O)O%10)[C@H](O)[C@H]7O)O[C@@H]6CSCCC(O)=O)O1)=O
Inchi: InChI=1S/C33H35N5O5/c1-22(39)38-28-20-24(33(42)43-4)10-15-27(28)30(32(38)41)31(23-8-6-5-7-9-23)34-25-11-13-26(14-12-25)36(3)29(40)21-37-18-16-35(2)17-19-37/h5-15,20,34H,16-19,21H2,1-4H3/b31-30+
Analytical method development and validation for the estimation of sugammadex
By Parekh, Hemangi; Chokshi, Parin; Mashru, Rajashree
From Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.
Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay
By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H
From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.